SOHO 2022 Tenth Annual Meeting


 

SOHO 2022: AGILE - A Phase 3, Global, Randomized, Double-Blind Study of Ivo + Aza vs. Placebo + Aza in Newly Diagnosed AML With an IDH1 Mutation

19 views
October 14, 2022
Comments 0
Login to view comments. Click here to Login